Endometriun Flashcards
Endometrial hyperplasia
Either drugs or anovulatory
- menopause
- ERT (relieve menopause symptoms)
- PCOS/granulosa cell tumor
- obesity
1% of simple hyperplasia progress to
Adeno ca
Cystic hyperplasia occurs in
Hyperplastic endometrium
Menopause or postmenopause
Complex hyperplasia vs simple
Simple - crowding
Complex - crowding and branching
Complex hyperplasia to adenoCA
3%
Complex hyperplasia is a variant of
Adenomatous hyperplasia with mod to severe architectural atypia
Commonly progress to adenoCA
Complex hyperplasia
Cytologic atypia
- Large nuclei of varied size and shape
- increase N:C ratio
- Prominent nucleoli
- irreg clumped chromatin
Premalignant
Atypical hyperplasia (complex)
Vaginal discharge
Abd pain
Intermenstrual bleeding
HMB
Endo hyperplasia
Percent endo hyperplasia to endoCA
1.6%
Mgmt of endo hyperplasia
Hysterectomy
Atypical hyperplasia versus carcinoma
No invasion of connective tissue
Atypical hyperplasia to CA
22%
Risk of progression to endo CA
Simple 1% 8% Complex 3% 6% 29% adenomatous 9%
Diagnosis of endo hyperplasia
Fractional curettage
- choice
- endocervix and endometrium
- 30 and above
Endo sampling, brushing, biopsy or vacuum curettage
- 74-97% accurate for endo CA
- 32-70% endo hyperplasia
Pap smear endo CA accuracy
<50%
Endo hyperplasia
Young women desiring fertility
3-6 mos progestin therapy oral or IUD then repeat sampling
Peri and postmenopausal who have hyperplasia w/o atypia
3-6 mos progestin then repeat sampling
Complex atypical hyperplasia treatment
Hysterectomy
Postmenopausal bleeding or irregular menses
Endo CA
Median age endo CA
Range
61
50-59
Risk factors for endo CA
Early menarche (<12) Late menopause (>52) Functioning ovarian tumor Anovulation/PCOS Infertility Ovesity Tamoxifen Comorbidities Radiation
Syndrome associated with endo CA
Lynch II syndrome
Auto dominant
Endo CA is 2nd most common
Dec risk endo CA
High parity (cervical CA) OCPs
Most common histologic type of endo CA
Endometrioid CA
AdenoCA coexisting with benign squamous
malignant squamous
Adenoacanthoma
Adenosquamous
2 causes of endo CA
- Excess endogenous estrogen
- absence of hyperestrogenism
Endo CA with endo hyperplasia
Excess endogenous estrogen
- well or mod differentiated
- myometrial invasion is superficial
- good prognosis
Endo CA with atrophic endometrium
Absence of hyperestrogenism
- poor differentiated
- aggressive
Histologic grade of endo CA
Well - 95% glandular
Mod - 5-50% solid
Poor - >50% solid
Histologic grade of endo CA correlates with
- myometrial invasion
- pelvic and paraaortic nodes
- survival
Endo CA ancillaries
Peritoneal washings
DNA ploudy analyzer (aneuploid poor prognosis)
Biochemical assay (more reliable)
Endo CA treatment
Surgery
Explore lap, TAHBSO, peritoneal fluid cytology, lymph node dissection
Endo CA
given post-op to patients with more than stage 1B
Radiotherapy
Endometrial polyp diagnosis
Procedure
Vaginal utz
Hyperechoic <2cm
Hysteroscopy and biopsy
Excise thru hysteroscope with D&C